PubMed Central (PMC) Search Page
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2017 | 40 |
| 2018 | 29 |
| 2019 | 33 |
| 2020 | 33 |
| 2021 | 103 |
| 2022 | 96 |
| 2023 | 136 |
| 2024 | 291 |
| 2025 | 454 |
| 2026 | 369 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"NPJ Precis Oncol"[Journal]
1,584
results
Embargoed Articles:
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Loss of BAX in a neuroblastoma patient reveals delayed apoptosis but sustained chemotherapy sensitivity.
- Molero-Valenzuela A, de Rojas-P I, Pons G, Pérez-García MJ, Guillén G, Vilaplana A, Manresa-Vera S, Pérez-Albert P, Garrido M, Valero-Arrese L, Hladun R, Sánchez-Guixé M, Miera-Maluenda M, Boloix A, Roma J, Soriano A, Moreno L, Segura MF.
- NPJ Precis Oncol. 2026 Jul 2;10(1):401. doi: 10.1038/s41698-026-01585-w.
- PMCID: PMC13691093
Molero-Valenzuela A, et al.NPJ Precis Oncol. 2026.PMCID: PMC13691093 -
Explainable machine learning to predict immunotherapy outcomes in metastatic renal cell carcinoma - Meet-URO 15-AI study.
- Rebuzzi SE, Miskovic V, Fornarini G, Ferri S, Buti S, Piceni M, Signori A, Provenzano L, Banna GL, Rescigno P, Maruzzo M, Bimbatti D, Pollone BR, Basso U, De Giorgi U, Pedrazzoli P, Galli L, Zucali PA, Di Costanzo F, Ghose A, Pedrocchi ALG, Prelaj A.
- NPJ Precis Oncol. 2026 Jul 2;10(1):402. doi: 10.1038/s41698-026-01576-x.
- PMCID: PMC13691107
Rebuzzi SE, et al.NPJ Precis Oncol. 2026.PMCID: PMC13691107 -
Precision oncology in advanced melanoma: molecular landscapes and personalized therapy recommendations from the Molecular Tumor Board Freiburg.
- Lowinus T, Schipperges V, Metzger P, Brummer T, Matysiak U, Dopfer EP, Hess ME, Fahrner M, Pauli T, Blaumeiser A, Becker H, Kuehn J, Rassner M, Falkenstein J, Bertemes H, Bovio P, Pinter N, Cysar S, Lehr S, Wäsch R, Gräßel L, Eyerich K, Schultheis AM, Schilling O, Lassmann S, Werner M, Illert AL, Duyster J, Zeiser R, Miething CC, Boerries M, Meiss F, Rafei D.
- NPJ Precis Oncol. 2026 Oct 21;10(1):400. doi: 10.1038/s41698-026-01763-w.
- PMCID: PMC13687070
Lowinus T, et al.NPJ Precis Oncol. 2026.PMCID: PMC13687070 -
GLP-1 receptor agonist targets an AMPKα1-HIF1α-PFKFB3 metabolic vulnerability and enhances Lenvatinib response in hepatocellular carcinoma.
- Noma T, Li Y, Wada Y, Morine Y, Ikemoto T, Saito Y, Shimada M, Goel A.
- NPJ Precis Oncol. 2026 Jun 29;10(1):399. doi: 10.1038/s41698-026-01584-x.
- PMCID: PMC13680616
Noma T, et al.NPJ Precis Oncol. 2026.PMCID: PMC13680616 -
OncoGen.AI: an integrated platform for automated genomic analysis and reporting in precision oncology.
- Shome R, Kumar S, Mohanty SK, Dholakia D, Sharma A, Solanki S, Sharma S, Chauhan S, Satija S, Diwan H, Panigrahi MK, Tayal J, Mehta A, Ahuja G.
- NPJ Precis Oncol. 2026 Jun 27;10(1):398. doi: 10.1038/s41698-026-01578-9.
- PMCID: PMC13677748
Shome R, et al.NPJ Precis Oncol. 2026.PMCID: PMC13677748 -
Machine learning uncovers previously undetectable genetic deletions in cancer panel sequencing.
- Kerle IA, Husak O, Gross T, Hartig A, Prause R, Richter D, Brückmann S, Werner M, Kögler A, Hanf D, Möhrmann L, William D, Wendt K, Pfarr N, Mogler C, Aust DE, Schröck E, Heining C, Glimm H.
- NPJ Precis Oncol. 2026 Oct 16;10(1):397. doi: 10.1038/s41698-026-01756-9.
- PMCID: PMC13675215
Kerle IA, et al.NPJ Precis Oncol. 2026.PMCID: PMC13675215 -
Spatiotemporal multi-omics reveals lineage, spatial and functional heterogeneity of tumor-associated macrophages and therapeutic vulnerabilities in the tumor microenvironment.
- Wang T, Yang D, Wu J, Zhao X, Dong W, Zhang H, Lei T, Li J, Dan Y, Li T, Cai Z, Song Q, Xu B.
- NPJ Precis Oncol. 2026 Jul 25;10(1):393. doi: 10.1038/s41698-026-01622-8.
- PMCID: PMC13672365
Wang T, et al.NPJ Precis Oncol. 2026.PMCID: PMC13672365 -
Early functional reactivity to a CEACAM5 x CD3 T cell bispecific antibody in solid tumors associates with baseline immune contexture rather than target antigen density alone.
- Wilson S, Silva A, Serrano-Serrano ML, Karanikas V, Waldhauer I, Schoenle A, Bar V, Salpeter SJ, D'Arcangelo E, Lutolf M, Gjorevski N, Nair N.
- NPJ Precis Oncol. 2026 Aug 14;10(1):394. doi: 10.1038/s41698-026-01643-3.
- PMCID: PMC13672796
Wilson S, et al.NPJ Precis Oncol. 2026.PMCID: PMC13672796 -
Skill-guided agentic reasoning enables longitudinal synthesis of myeloma records at expert-level concordance.
- Moll J, Lübberstedt J, Nuernbergk C, Stroh J, Mertens L, Purcarea A, Zirn C, Benchaaben Z, Drexel F, Häntze H, Narayanan A, Puttkammer F, Zhukov A, Lammert J, Ziegelmayer S, Graf M, Högner M, Makowski M, Bassermann F, Adams LC, Pan J, Rueckert D, Braitsch K, Bressem KK.
- NPJ Precis Oncol. 2026 Oct 14;10(1):389. doi: 10.1038/s41698-026-01733-2.
- PMCID: PMC13669396
Moll J, et al.NPJ Precis Oncol. 2026.PMCID: PMC13669396 -
Decoding spatial mTOR signalling reveals distinct roles in the tumour microenvironment.
- Zuhair R, Eastwood M, Bradbury M, Cross A, Hester J, Issa F, Ginty F, Sailem HZ.
- NPJ Precis Oncol. 2026 Sep 25;10(1):388. doi: 10.1038/s41698-026-01674-w.
- PMCID: PMC13669363
Zuhair R, et al.NPJ Precis Oncol. 2026.PMCID: PMC13669363